D
Veradermics, Incorporated MANE
$126.89 $7.526.30% NYSE
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

03/31/2026 12/31/2025
Total Cash And Short-Term Investments 636.19% 167.24%
Total Receivables -- -8.73%
Inventory -- --
Prepaid Expenses -- 440.37%
Finance Division Loans and Leases Current -- --
Total Finance Division Other Current Assets -- --
Other Current Assets -- 9,815.79%
Total Current Assets -- 174.59%

Total Current Assets -- 174.59%
Net Property, Plant & Equipment -- --
Long-term Investments -- --
Goodwill -- --
Total Other Intangibles -- --
Finance Div Loans & Leases LT -- --
Total Finance Div Other LT Assets -- --
Total Other Assets -- --
Total Assets -- 174.82%

Total Accounts Payable -- -5.43%
Total Accrued Expenses -- 182.55%
Short-term Debt -- --
Current Portion of Long-Term Debt/Capital Leases -- --
Finance Division Debt Current -- --
Total Finance Division Other Current Liabilities -- --
Total Other Current Liabilities -- --
Total Current Liabilities -- 93.98%

Total Current Liabilities -- 93.98%
Long-Term Debt -- --
Short-term Debt -- --
Capital Leases -- --
Finance Division Debt Non Current -- --
Total Finance Division Other Non Current Liabilities -- --
Total Other Liabilities -- --
Total Liabilities -- 94.07%

Common Stock & APIC -- 212.52%
Retained Earnings -- -150.70%
Treasury Stock & Other -- 53.51%
Total Common Equity 846.52% -134.79%

Preferred Stock Redeemable -- --
Preferred Stock Non Redeemable -- --
Preferred Stock Convertible -- 158.21%
Preferred Stock, Others -- --
Total Preferred Equity -- 158.21%

Total Common Equity 846.52% -134.79%
Total Preferred Equity -- 158.21%
Total Minority Interest -- --
Total Equity 668.72% 182.31%